Three-dimensional Quantitative Structure–activity Relationship, Molecular Docking and Absorption, Distribution, Metabolism, and Excretion Studies of Lidocaine Analogs Pertaining to Voltage-gated Sodium Channel Nav1.7 Inhibition for the Management of Neuropathic Pain

Aim: This study aims to design and develop novel lidocaine analogs specific for the Nav1.7 channel using in silico approaches. Background: Neuropathic pain (NP) is defined as chronic pain originating from abnormalities found within the nervous system. Voltage-gated sodium channels play a significant role in enhancing neuronal excitability, thus gained significance as a crucial target for developing drugs to treat NP. It consists of 9 different isoforms, with Nav1.7 predominantly found in the dorsal root ganglion, playing a crucial role in the pathophysiology of NP. The selective inhibitors targeting the Nav1.7 channel hold greater potential for treating NP while minimizing interference with the physiological functions of other sodium channel isoforms. Methods: Atom and field-based three-dimensional (3D) quantitative structure–activity relationship (QSAR) was created using lidocaine analogs to identify the structural features required for the Nav1.7 inhibitory activities. Further, the molecular interaction of the scaffold with the Nav1.7 channel VSD4 was studied by docking the molecules with it followed by absorption, distribution, metabolism, and excretion (ADME) analysis. Results: The 3D QSAR studies revealed that the presence of hydrophobic groups and steric parameters heightened the specificity for Nav1.7 channel. Docking analysis revealed that 4 compounds, i.e., A15, A14, A6, and A5, exhibited the highest binding affinity in comparison to reference drug lidocaine. Furthermore, ADME predictions indicated that the compounds exhibited favorable characteristics in terms of oral bioavailability and solubility. Conclusion: This research offers valuable structural insights to improve the specific inhibition of the Nav1.7 channel, facilitating the design and development of novel, Nav1.7 channel-specific inhibitors.

• Publication year

  2025

• Venue

  International Journal of Applied and Basic Medical Research

• Publication date

  2025-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.4103/ijabmr.ijabmr_347_24PMID 40937022PMCID 12422546
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The neuropathic pain: An overview of the current treatment and future therapeutic approaches

  2019cited by this paper
• Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist

  2015influential reference
• Recent progress in sodium channel modulators for pain.

  2014influential reference
• Neuropathic pain in the general population: A systematic review of epidemiological studies

  2014cited by this paper
• Sodium channels, inherited epilepsy, and antiepileptic drugs.

  2014influential reference
• Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments

  2013cited by this paper
• Axonal voltage-gated ion channels as pharmacological targets for pain.

  2013cited by this paper
• Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels

  2013cited by this paper
• Advances in Targeting Voltage‐Gated Sodium Channels with Small Molecules

  2012influential reference
• Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field.

  2010cited by this paper
• 3D-QSAR in drug design--a review.

  2010cited by this paper
• Synthesis and antispasmodic activity of lidocaine derivatives endowed with reduced local anesthetic action.

  2008cited by this paper
• PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results

  2006cited by this paper
• International Union of Pharmacology. XLVII. Nomenclature and Structure-Function Relationships of Voltage-Gated Sodium Channels

  2005cited by this paper
• Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

  2004cited by this paper
• Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening.

  2004cited by this paper
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

  2001cited by this paper
• Regulation of Na+ channel distribution in the nervous system.

  2001cited by this paper
• Diversity of Mammalian Voltage‐Gated Sodium Channels

  1999cited by this paper
• Structure and function of voltage-gated ion channels.

  1995cited by this paper
• The receptor for tetrodotoxin and saxitoxin. A structural hypothesis.

  1975cited by this paper
• The Inhibition of Sodium Currents in Myelinated Nerve by Quaternary Derivatives of Lidocaine

  1973cited by this paper

• No citing papers are available for this paper.